RxDoctor Payments Data

Manish Varma, MD

Vascular & Interventional Radiology · Grand Rapids, MINPI 1669445631

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Trisalus Life Sciences, Inc. at 49.7% of the total. Reporting peaked in 2023 at $4,371 and has fallen 78.1% since, to $957 in 2025.

$7,898in general payments, 2019–2025

Across 81 payments — averaging $97.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trisalus Life Sciences, Inc.$4K
  • Inari Medical, Inc.$2K
  • Stryker$690
  • Sirtex Medical Inc$341
  • Penumbra, Inc.$303
  • Siemens Medical Solutions USA, Inc.$252
  • plus $843 from 11 others
$1,594in research payments, 2019–2025

Across 2 payments — averaging $797.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$2K

What the payments were for

  • Speaking & faculty fees$3,00038%
  • Travel & lodging$78310%
  • Food & beverage$4,11552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,898 in reported general payments places this provider in the 80th percentile of 118 vascular & interventional radiology providers in Michigan.

See all vascular & interventional radiology providers in Michigan

Medicare billing

Part B allowed, 2024
$93,447
Medicare patients
409
Services billed
1,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →